An open label, comparative, multicentric study to assess the efficacy and safety of fixed dose combination tablets of Nebivolol & Indapamide (as sustained release) in comparison with Nebivolol tablets in patients suffering from hypertension.

Trial Profile

An open label, comparative, multicentric study to assess the efficacy and safety of fixed dose combination tablets of Nebivolol & Indapamide (as sustained release) in comparison with Nebivolol tablets in patients suffering from hypertension.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2016

At a glance

  • Drugs Indapamide/nebivolol (Primary) ; Nebivolol
  • Indications Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Cadila Healthcare
  • Most Recent Events

    • 10 Apr 2010 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.
    • 19 Mar 2010 Status changed from recruiting to active, no longer recruiting as reported by Clinical Trials Registry - India
    • 08 Feb 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top